This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Vallon Pharmaceuticals Past Earnings Performance
Past criteria checks 0/6
Key information
-25.1%
Earnings growth rate
15.5%
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | -100.0% |
| Return on equity | -299.9% |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Vallon Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 0 | -7 | 6 | 1 |
| 30 Sep 22 | 0 | -9 | 5 | 4 |
| 30 Jun 22 | 0 | -9 | 5 | 4 |
| 31 Mar 22 | 0 | -9 | 5 | 5 |
| 31 Dec 21 | 0 | -9 | 4 | 5 |
| 30 Sep 21 | 0 | -8 | 3 | 4 |
| 30 Jun 21 | 0 | -7 | 2 | 5 |
| 31 Mar 21 | 0 | -6 | 2 | 5 |
| 31 Dec 20 | 0 | -5 | 1 | 4 |
| 30 Sep 20 | 0 | -4 | 1 | 3 |
| 30 Jun 20 | 0 | -4 | 1 | 3 |
| 31 Mar 20 | 0 | -4 | 1 | 2 |
| 31 Dec 19 | 0 | -3 | 1 | 2 |
Quality Earnings: VLON is currently unprofitable.
Growing Profit Margin: VLON is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VLON is unprofitable, and losses have increased over the past 5 years at a rate of 25.1% per year.
Accelerating Growth: Unable to compare VLON's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VLON is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (7.6%).
Return on Equity
High ROE: VLON has a negative Return on Equity (-299.91%), as it is currently unprofitable.